333 related articles for article (PubMed ID: 31974023)
1. Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation.
Gladding PA; Legget M; Fatkin D; Larsen P; Doughty R
Heart Lung Circ; 2020 Apr; 29(4):634-640. PubMed ID: 31974023
[TBL] [Abstract][Full Text] [Related]
2. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P
Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk scores in atrial fibrillation: Associations and clinical utility in disease prediction.
Gibson JT; Rudd JHF
Heart Rhythm; 2024 Jun; 21(6):913-918. PubMed ID: 38336192
[TBL] [Abstract][Full Text] [Related]
4. Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank.
Choi SH; Jurgens SJ; Weng LC; Pirruccello JP; Roselli C; Chaffin M; Lee CJ; Hall AW; Khera AV; Lunetta KL; Lubitz SA; Ellinor PT
Circ Res; 2020 Jan; 126(2):200-209. PubMed ID: 31691645
[TBL] [Abstract][Full Text] [Related]
5. Polygenic predisposition to breast cancer and the risk of coronary artery disease.
D'Souza M; Schou M; Skals R; Weeke PE; Lee C; Smedegaard L; Madelaire C; Gerds TA; Poulsen HE; Hansen T; Grarup N; Pedersen O; Stender S; Engstrøm T; Fosbøl E; Nielsen D; Gislason G; Køber L; Torp-Pedersen C; Andersson C
Int J Cardiol; 2019 Sep; 291():145-151. PubMed ID: 31155334
[TBL] [Abstract][Full Text] [Related]
6. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
[TBL] [Abstract][Full Text] [Related]
7. Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke.
Kim J; Kim D; Bae HJ; Park BE; Kang TS; Lim SH; Lee SY; Chung YH; Ryu JW; Lee MY; Yang PS; Joung B
Cardiovasc Diabetol; 2024 Jan; 23(1):5. PubMed ID: 38172896
[TBL] [Abstract][Full Text] [Related]
8. [Genetic testing in polygenic diseases : Atrial fibrillation, arterial hypertension and coronary artery disease].
Trenkwalder T; Kessler T; Schunkert H
Herz; 2017 Aug; 42(5):440-448. PubMed ID: 28536780
[TBL] [Abstract][Full Text] [Related]
9. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
Inouye M; Abraham G; Nelson CP; Wood AM; Sweeting MJ; Dudbridge F; Lai FY; Kaptoge S; Brozynska M; Wang T; Ye S; Webb TR; Rutter MK; Tzoulaki I; Patel RS; Loos RJF; Keavney B; Hemingway H; Thompson J; Watkins H; Deloukas P; Di Angelantonio E; Butterworth AS; Danesh J; Samani NJ;
J Am Coll Cardiol; 2018 Oct; 72(16):1883-1893. PubMed ID: 30309464
[TBL] [Abstract][Full Text] [Related]
10. Genomic basis of atrial fibrillation.
Bapat A; Anderson CD; Ellinor PT; Lubitz SA
Heart; 2018 Feb; 104(3):201-206. PubMed ID: 28893835
[TBL] [Abstract][Full Text] [Related]
11. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
[TBL] [Abstract][Full Text] [Related]
12. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
[TBL] [Abstract][Full Text] [Related]
13. GWAS contribution to atrial fibrillation and atrial fibrillation-related stroke: pathophysiological implications.
Cruz D; Pinto R; Freitas-Silva M; Nunes JP; Medeiros R
Pharmacogenomics; 2019 Jul; 20(10):765-780. PubMed ID: 31368859
[TBL] [Abstract][Full Text] [Related]
14. Polygenic risk scores for the prediction of cardiometabolic disease.
O'Sullivan JW; Ashley EA; Elliott PM
Eur Heart J; 2023 Jan; 44(2):89-99. PubMed ID: 36478054
[TBL] [Abstract][Full Text] [Related]
15. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
[TBL] [Abstract][Full Text] [Related]
16. Genetics of atrial fibrillation-an update of recent findings.
Manoharan A; Sambandam R; Ballambattu VB
Mol Biol Rep; 2022 Aug; 49(8):8121-8129. PubMed ID: 35587846
[TBL] [Abstract][Full Text] [Related]
17. Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits.
So HC; Sham PC
Bioinformatics; 2017 Mar; 33(6):886-892. PubMed ID: 28065900
[TBL] [Abstract][Full Text] [Related]
18. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.
Elliott J; Bodinier B; Bond TA; Chadeau-Hyam M; Evangelou E; Moons KGM; Dehghan A; Muller DC; Elliott P; Tzoulaki I
JAMA; 2020 Feb; 323(7):636-645. PubMed ID: 32068818
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development.
Nielsen JB; Fritsche LG; Zhou W; Teslovich TM; Holmen OL; Gustafsson S; Gabrielsen ME; Schmidt EM; Beaumont R; Wolford BN; Lin M; Brummett CM; Preuss MH; Refsgaard L; Bottinger EP; Graham SE; Surakka I; Chu Y; Skogholt AH; Dalen H; Boyle AP; Oral H; Herron TJ; Kitzman J; Jalife J; Svendsen JH; Olesen MS; Njølstad I; Løchen ML; Baras A; Gottesman O; Marcketta A; O'Dushlaine C; Ritchie MD; Wilsgaard T; Loos RJF; Frayling TM; Boehnke M; Ingelsson E; Carey DJ; Dewey FE; Kang HM; Abecasis GR; Hveem K; Willer CJ
Am J Hum Genet; 2018 Jan; 102(1):103-115. PubMed ID: 29290336
[TBL] [Abstract][Full Text] [Related]
20. Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype?
German CA; Shapiro MD
Curr Atheroscler Rep; 2021 Jun; 23(9):47. PubMed ID: 34181090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
